Colorectal carcinoma (CRC) remains the major cause of cancer death in humans. Although chromosomal structural anomaly is presumed to play an important role in the carcinogenesis of CRC, chromosomal copy number alterations (CNA) and loss of heterozygosity (LOH) have not yet been analyzed extensively at high resolution in CRC. Here we aim to identify recurrent CNA and LOH in human CRC with the use of single nucleotide polymorphism-typing microarrays, and to reveal their relevance to clinical outcome. Surgically resected CRC specimens and paired normal mucosa were obtained from a consecutive series of 94 patients with CRC, and both of them were subjected to genotyping with Affymetrix Mapping 50K arrays. CNA and LOH were inferred computationally on every single nucleotide polymorphism site by integrating the array data for paired specimens. Our large dataset reveals recurrent CNA in CRC at chromosomes 7, 8, 13, 18, and 20, and recurrent LOH at chromosomes 1p, 4q, 5q, 8p, 11q, 14q, 15q, 17p, 18, and 22. Frequent uniparental disomy was also identified in chromosomes 8p, 17p, and 18q. Very common CNA and LOH were present at narrow loci of <1 Mbp containing only a few genes. In addition, we revealed a number of novel CNA and LOH that were linked statistically to the prognosis of the patients. The precise and large-scale measurement of CNA and LOH in the CRC genome is efficient for pinpointing prognosis-related genome regions as well as providing a list of unknown genes that are likely to be involved in CRC development.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11158266 | PMC |
| http://dx.doi.org/10.1111/j.1349-7006.2008.00881.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma.
Br J Dermatol
December 2024
Victorian Melanoma Service, The Alfred Hospital, Melbourne, VIC, Australia.
Article Synopsis
- A significant portion (2-20%) of cutaneous melanoma cases are diagnosed as amelanotic/hypopigmented melanoma (AHM), which complicates early detection due to their lack of pigmentation.
- The study investigates mutations in key pigmentation genes linked to albinism and hypopigmentation, revealing that AHM patients have a higher frequency of rare germline variants compared to pigmented melanoma patients.
- Findings include that specific gene variants associated with red hair pigmentation are common in AHM cases, and some AHM tumors show chromosomal abnormalities related to these pigmentation genes, indicating a genetic basis for the lack of pigmentation in these melanomas.
Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas.
Exp Mol Pathol
October 2024
Department of Pathology, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), CUB Hôpital Érasme, Route de Lennik, 808 1070 Brussels, Belgium. Electronic address:
Pancreatic ductal adenocarcinoma (PDAC) is reported to be amongst the cancers with the lowest survival rate at 5 years. In the present study we aimed to validate a targeted next-generation sequencing (tNGS) panel to use in clinical routine, investigating genes important for PDAC diagnostic, prognostic and potential theragnostic aspect. In this NGS panel we also designed target regions to inquire about loss of heterozygosity (LOH) of chromosome 18 that has been described to be possibly linked to a worse disease progression.
View Article and Find Full Text PDFCancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization.
Methods Mol Biol
June 2024
Department of Pathology and Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Chromosomal microarray, including single-nucleotide polymorphism (SNP) array and array comparative genomic hybridization (aCGH), enables the detection of DNA copy-number loss and/or gain associated with unbalanced chromosomal aberrations. In addition, SNP array and aCGH with SNP component also detect copy-neutral loss of heterozygosity (CN-LOH). Here we describe the chromosomal microarray procedure from the sample preparation using extracted DNA to the scanning of the array chip.
View Article and Find Full Text PDFMolecular landscape of proliferative verrucous leukoplakia: a systematic review.
Br J Oral Maxillofac Surg
February 2024
Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Institute for Life Sciences, University of Southampton, Southampton, UK.
Article Synopsis
- Proliferative verrucous leukoplakia (PVL) is a rare oral condition with a potential to evolve into oral cancers, lacking predictive biomarkers for its progression.
- A review of 685 cases revealed PVL’s genomic profile includes initial high loss of heterozygosity (LOH) and low copy number alterations, with later mutations found in specific genes but no TP53 mutations.
- Differences in LOH and specific chromosomal deletions and amplifications suggest similarities with oral verrucous carcinoma (OVC) and oral squamous cell carcinoma (OSCC), indicating a need for further research to clarify PVL's genomic landscape.
Added value of molecular karyotype in childhood acute lymphoblastic leukemia.
Cancer Innov
December 2023
Hematology Biology, CHU Nantes, Nantes Université Univ Angers, INSERM, CNRS, CRCI2NA Nantes France.
Background: Thanks to an improved therapeutic regimen in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL), 5 year-overall survival now exceeds 90%. Unfortunately, the 25% of children who relapse have an initial poor prognosis, potentially driven by pre-existing or emerging molecular anomalies. The latter are initially and essentially identified by cytogenetics.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!